CD8A and Alzheimer disease: With this unprecedented observation, we speculate that CD8+ T cells are involved in the late stage of T-cell activation since PD-1 acts as a senescence marker of T-cell differentiation and is prone to be inhibited by the PD-1/PD-L1 pathway in moderate AD patients.